Ark Solutions Inc (KOSDAQ:203690)
4,425.00
-75.00 (-1.67%)
At close: Jan 22, 2025
Ark Solutions Revenue
Ark Solutions had revenue of 7.39B KRW in the quarter ending March 31, 2026, with 33.89% growth. This brings the company's revenue in the last twelve months to 17.95B, down -41.97% year-over-year. In the year 2025, Ark Solutions had annual revenue of 16.08B, down -51.61%.
Revenue (ttm)
17.95B
Revenue Growth
-41.97%
P/S Ratio
3.84
Revenue / Employee
326.34M
Employees
55
Market Cap
68.91B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 16.08B | -17.15B | -51.61% |
| Dec 31, 2024 | 33.23B | -4.03B | -10.81% |
| Dec 31, 2023 | 37.25B | 10.68B | 40.18% |
| Dec 31, 2022 | 26.58B | -6.26B | -19.07% |
| Dec 31, 2021 | 32.84B | 15.14B | 85.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CTCBIO | 128.76B |
| KoBioLabs | 71.21B |
| Naturalendo Tech | 21.69B |
| BIO-FD&C | 18.85B |
| PanGen Biotech | 13.71B |
| TegoScience | 5.83B |
| EyeGene | 4.02B |
| SunBio,Inc. | 2.17B |